1-8 of 8
Patrick Harrington
Close
Sort by
Journal Articles

An 8-Year Retrospective Review of Human Albumin Solution (HAS) Use August 2015 to March 2023; Guy's and St Thomas' NHS Foundation Trust (GSTFT)

Asma Tameez Ud Din, Patrick Harrington, Danaee Anicee, Muhammad Sajid Yazdani, Paul Holmes, Andrew Retter, Susan Robinson
Journal: Blood
Blood (2023) 142 (Supplement 1): 5571.
https://doi.org/10.1182/blood-2023-172759
Published: 2023
Journal Articles

Enhanced Cardiovascular Risk Assessment Incorporating Natural Language Processing and Qrisk-3 Score Determination in Patients with Essential Thrombocythaemia

Patrick Harrington, Andrea Duminuco, Joshua Au Yeung, Sukhraj Singh Virdee, Raj Vaghela, Susan Asirvatham, Rosemarie Bone, Claire Woodley, Kyaw Htin Thaw, Llywelyn Cadman-Davies, Jennifer O'Sullivan, Priya Sriskandarajah, Natalia Curto-Garcia, Shahram Kordasti, Hugues de Lavallade, Deepti H. Radia, James Teo, Claire N Harrison
Journal: Blood
Blood (2023) 142 (Supplement 1): 4561.
https://doi.org/10.1182/blood-2023-180536
Published: 2023
Journal Articles

Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients

Patrick Harrington, Katie Doores, Chandan Saha, Jamie Saunders, Deepti H. Radia, Shahram Kordasti, Richard Dillon, Kavita Raj, Jeffrey Seow, Carl Graham, Thomas Lechmere, Sukran Saglam, Fiona Child, Amy O'Reilly, Andreas Espehana, Varun Mehra, Donal P. McLornan, Michael Malim, Claire N. Harrison, Hugues de Lavallade
Journal: Blood
Blood (2021) 138 (Supplement 1): 3920.
https://doi.org/10.1182/blood-2021-152287
Published: 2021
Journal Articles

Immune Checkpoint Analysis of T Effectors and Regulatory T Cells in Patients with CML Reveals Increased Expression at Diagnosis and with Refractory Disease

Patrick Harrington, Richard Dillon, Deepti H. Radia, Donal P. McLornan, Claire Woodley, Susan Asirvatham, Kavita Raj, Natalia Curto-Garcia, Shahram Kordasti, Claire N. Harrison, Hugues de Lavallade
Journal: Blood
Blood (2021) 138 (Supplement 1): 2545.
https://doi.org/10.1182/blood-2021-150533
Published: 2021
Journal Articles

Inhibition of Immune Cell Subsets Is Differentially Affected By Dasatinib Dosage in Patients with Chronic Phase CML

Patrick Harrington, MRCP, FRCPath, Richard Dillon, MA, PhD MRCP, FRCPath, Deepti H. Radia, MRCPI, FRCPath, Donal P. McLornan, MRCP, PhD FRCPath, Philippe Rousselot, MDPhD, Katayoun Rezvani, MD PhD, Shahram Kordasti, MD PhD, Claire Harrison, DM, FRCP, FRCPath, Hugues de Lavallade, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–53.
https://doi.org/10.1182/blood-2020-139501
Published: 2020
Journal Articles

Mechanistic Insights into the Inhibition of T Regulatory Cells By Dasatinib May Predict Immunostimulatory Effects in CML Patients

Patrick Harrington, MRCP, FRCPath, Richard Dillon, MA, PhD MRCP, FRCPath, Philippe Rousselot, MD PhD, Deepti Radia, Yvonne Francis, Claire N Harrison, Professor, Shahram Kordasti, MD PhD, Hugues De Lavallade
Journal: Blood
Blood (2019) 134 (Supplement_1): 1635.
https://doi.org/10.1182/blood-2019-129135
Published: 2019
Journal Articles

Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy

Hugues De Lavallade, Sophie Jackson, BSc, Heather Oakervee, BSc, MBBS, MD MRCP, FRCPath, Sebastian Francis, MBChB, MRCP, Edward Belsham, FRCPath, MB, Paul Cahalin, MA MRCP FRCPath, Joanne Ewing, PhDBMBS BSc FRPATH, Jenny Byrne, MD PhD, Kate Rothwell, BA MB BChir, PhD, Sandra Hassan, MBBS, MRCP, FRCPath, MDRes), Srinivas Pillai, MBBS,MD MRCP, FRCPath, Priyanka Mehta, Anshu Garg, MBBS,MDMRCP,FRCPath, Mhairi Copland, PhD MBBChir, FRCP, FRCPath, Oliver Ottmann, Prof, MD, Deepti Radia, Patrick Harrington, MRCP, FRCPath, Rachel Greig, Nicholas Lea, PhD, Michael Thompson, Aytug Kizilors, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2935.
https://doi.org/10.1182/blood-2019-129825
Published: 2019
Journal Articles

Clinical Intervention Using NGS-Based Kinase Domain Mutation Testing in CML Patients

Aytug Kizilors, PhD, Patrick Harrington, FRCPath, MRCP, Sophie Jackson, BSc, Nicholas Lea, PhD, Joel Newman, MBBS, MRCP, BSc, FRCPath, Richard Gale, FRCPath, FRCP, Sandra Hassan, MD, Evangelia Dimitriadou, MD, Elena Crisà, MD, Luke Ficinski, BSc, Isabel Sa, BSc, Anita Arasaretnam, MD, Vijayavalli Dhanapal, MD, Timothy Corbett, FRCP, FRCPath, Robin M. Ireland, FRCP, Antonio Pagliuca, Ghulam J. Mufti, Hugues De Lavallade
Journal: Blood
Blood (2018) 132 (Supplement 1): 3025.
https://doi.org/10.1182/blood-2018-99-118905
Published: 2018